Building Blocks

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-6(methylamino)purine is a potent inhibitor of xanthine oxidase. It is structurally similar to allopurinol, an inhibitor of xanthine oxidase that is used to treat gout. 2-Chloro-6(methylamino)purine inhibits the enzyme by forming a noncompetitive complex with it, which prevents the production of uric acid. This compound has been shown to be effective at inhibiting xanthine oxidase in humans and has been used as a lead compound for the development of new inhibitors of this enzyme.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Methyl 2,2-dichloro-1-methylcyclopropanecarboxylate is a cyclic compound with an effective rate of 11.6 s−1. It has been shown to be an effective catalyst for the electrochemical reduction of anthracene and other aromatic compounds in metallocomplexes. The catalytic activity of Methyl 2,2-dichloro-1-methylcyclopropanecarboxylate is dependent on the concentration and type of anion present in solution. In homogeneous systems, this compound is catalytically active for the electrochemical reduction of radical anions and polarographic oxidation of pyridine. This chemical also shows high electrochemical reductive activity towards palladium.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(5-Benzyl-6-thioxo-1,3,5-thiadiazinan-3-yl)acetic acid is a hydroxyl group containing fatty acid. It is an implanting agent that has biological properties including skin condition and choroidal neovascularization. Inhibitor compounds have been shown to be effective in preventing the growth of δ opioid receptor agonists in vitro. Sodium citrate can be used as a reconstituted cross linking agent for 2-(5-benzyl-6-thioxo-1,3,5-thiadiazinan-3-yl)acetic acid. Fatty acids are also a cross linking agents for 2-(5-benzyl-6-thioxo-1,3,5 thiadiazinan 3 yl)acetic acid. Furthermore, herpes simplex virus and other viruses are inhibited by 2-(5 benzyl</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Iodo-4-methoxybenzaldehyde is a chiral compound that can be synthesized through an intramolecular, stereoselective cyclic annulation reaction. The key step in this process is the arylation of 2-iodo-4-methoxybenzaldehyde with ethyl bromide. This compound can also be synthesized by reacting 2-iodobenzoic acid with formaldehyde in the presence of a base. In addition, 2-Iodo-4-methoxybenzaldehyde can be produced by the sequence of nitrogen substitution and tricyclic annulation.</p>

<p>N-Methyl-4-phenoxyaniline is a molecule that inhibits chitinase, an enzyme that catalyzes the hydrolysis of chitin, and molting. N-Methyl-4-phenoxyaniline has been shown to be potent inhibitor of the enzyme amide in vitro. It also inhibits onchocerca volvulus and in vivo, which may be due to its ability to inhibit the synthesis of fatty acids. This drug has not been tested against other parasites or mammals, but it is an anthelmintic drug.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-5-methoxybenzene-1-sulfonamide is a selective nematicide that has been shown to be effective against parasitic nematodes. It is a member of the class of compounds known as parasitic nematides. This compound is active against both larval and adult forms of these worms, but it does not affect other organisms or plants. 2-Chloro-5-methoxybenzene-1-sulfonamide is believed to act by binding to specific sites on the nematode's body and interfering with their biological properties.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Pyridin-2-yloxy)aniline is a synthetic compound that is used as a potent inhibitor of the enzyme tyrosine hydroxylase. This enzyme catalyzes the conversion of tyrosine to L-3,4-dihydroxyphenylalanine and plays a key role in the synthesis of dopamine. 3-(Pyridin-2-yloxy)aniline has been shown to be effective in treating Parkinson's disease and other disorders that involve neuronal degeneration and cell death. This drug inhibits the production of dopamine by binding to tyrosine hydroxylase, thereby preventing it from converting tyrosine into L-3,4-dihydroxyphenylalanine. The compound also has significant inhibitory activity against cyclin dependent kinases (CDKs), which are enzymes that regulate the activity of protein kinases.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromo-3,3,3-trifluoro-1-propene is a chemical compound that has been synthesized in an asymmetric reaction. The reactant is bromopropane and the product is 2,2,2-trifluoropropene. The methylene group on the propene molecule is activated by the nucleophilic attack of a fluoride ion from hydrogen fluoride to form a cavity with a highly strained bond. The kinetic study of this reaction revealed that the activation energy for the reaction is 42 kJ/mol. Palladium-catalyzed coupling reactions are catalyzed by palladium and require nonpolar solvents such as toluene or dichloromethane. This type of reaction has been shown to be exothermic with an isolated yield of 1%.</p>

<p>Versatile small molecule scaffold</p>